GlassScriptPhysician profile
Jennifer Tseng
NPI 1962646992
$11,124.12
in general payments reported to CMS, 2019-2025
7 companies · $1,960 in 2025
The $1,960 reported for 2025 was more than what 81% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,548 · 2023: $5,658 · 2024: $1,958 · 2025: $1,960.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,848 · Education: $1,876 · Food and Beverage: $852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,848.14 |
| Education | $1,875.77 |
| Food and Beverage | $851.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,612.11 | 2023-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Axogen | $1,755.15 | 2025 | |
| Elucent Medical | $939.31 | 2022 | |
| Stryker Corporation | $609.15 | 2022 | |
| Dilon Technologies, INC. | $174.61 | 2025 | Hemoblast Bellows |
| Merit Medical Systems INC | $33.79 | 2023 | Savi Scout |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Tseng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.